CoChat

Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin‐induced insulin‐deficient diabetic mice by restoring brown adipose tissue function

Kim, J.‐H., Bae, K.‐H., Choi, Y.‐K., Go, Y., Choe, M., Jeon, Y.‐H., Lee, H.‐W., Koo, S.‐H., Perfield, J. W., Harris, R. A., Lee, I.‐K., Park, K.‐G. · 2015 · Diabetes, Obesity and Metabolism
Cited by 50

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Aim: To investigate the effects of LY2405319 , an analogue of fibroblast growth factor 21 ( FGF21 ), on glucose homeostasis in streptozotocin ( STZ )‐induced insulin‐deficient mice ( STZ mice). Methods: Nine‐week‐old male C57BL/6J mice were administered a single intraperitoneal injection of STZ (150 mg/kg). One week later, after confirmation of hyperglycaemia, saline or LY2405319 (5 mg/kg) was injected subcutaneously daily for 4 weeks. Changes in glucose homeostasis, energy metabolism and brown adipose tissue ( BAT ) function were assessed. Results: The STZ mice had elevated blood glucose and reduced plasma FGF21 levels, impaired glucose uptake in the BAT , and BAT mitochondria with absent or swollen cristae and fewer lipid vacuoles. LY2405319 significantly reduced blood glucose levels and this was associated with increased BAT glucose uptake and changes in gene expression and morphology, indicating improved mitochondrial lipid metabolism in the BAT . Importantly, the ability of LY2405319 to lower blood glucose in STZ mice was compromised after removing interscapular BAT . Conclusions: Our results show that LY2405319 reduces blood glucose levels in insulin‐deficient diabetes by improving BAT metabolism. Additional studies investigating the therapeutic potential of FGF21 for the treatment of type 1 diabetes are warranted.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/dom.12408

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 50

Metadata

Authors
Kim, J. ‐., Bae, K. ‐., Choi, Y. ‐., Go, Y., Choe, M., Jeon, Y. ‐., Lee, H. ‐., Koo, S. ‐., Perfield, J. W., Harris, R. A., Lee, I. ‐., & Park, K. ‐.
Venue
Diabetes, Obesity and Metabolism
Publisher
Wiley
Published
2014-11-28
Volume
17
Issue
2
Pages
161-169
ISSN
  • 1462-8902 (ISSN-L)
  • 1463-1326
OpenAlex
W2078451276
Cited by
50
References
12
FWCI
2.07
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin‐induced insulin‐deficient diabetic mice by restoring brown adipose tissue function. https://app.cochat.ai/papers/10.1111/dom.12408
The paper
Kim, J. ‐., Bae, K. ‐., Choi, Y. ‐., Go, Y., Choe, M., Jeon, Y. ‐., Lee, H. ‐., Koo, S. ‐., Perfield, J. W., Harris, R. A., Lee, I. ‐., & Park, K. ‐. (2015). Fibroblast growth factor 21 analogue LY2405319 lowers blood glucose in streptozotocin‐induced insulin‐deficient diabetic mice by restoring brown adipose tissue function. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.12408

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.